Kerrisdale Capital is a private investment manager that focuses on value and special situations investments. We manage investment partnerships and separately managed accounts.
I am a former hedge fund portfolio manager that trades for my own personal account. I espouse Graham and Dodd/Buffett style investing, always on the lookout for value equities or bonds. A graduate of Northwestern's Kellogg School of Management, I lived in NYC for a decade before relocating with my family to the Charlotte, NC area in 2007.
Alan Brochstein, CFA, was the first investment professional to devote himself to sharing his observations about the cannabis industry from an investor's perspective publicly. He runs 420 Investor, a subscription-based due diligence platform for investors interested in the publicly-traded cannabis stocks and is also the founder of New Cannabis Ventures, a content aggregation site focused on investors and entrepreneurs in the cannabis industry.
Alan has worked in the securities industry since 1986, primarily with the responsibility for managing investments in institutional environments until he founded AB Analytical Services in 2007 in order to provide independent research and consulting to registered investment advisors. In addition to advising several different hedge funds and investment managers, including Friedberg Investment Management, where he participated as a member of its investment management committee, Alan was also a senior analyst for the independent research firm Management CV. In 2008, he began providing a first-of-its-kind subscription-based service for individual investors, Invest By Model, which offered two different portfolios that investors could replicate in their own accounts for $20 per month. Alan also offered The Analytical Trader at Marketfy, where he used fundamental and technical analysis in a disciplined process to offer specific trade ideas geared towards swing traders.
Alan launched www.420Investor.com in late 2013 as the premier source of information for "Green Rush" investors seeking to capitalize on the proliferation of legalized medical and recreational cannabis. In March 2014, Alan, who is a member of the National Cannabis Industry Association, began to focus solely on the cannabis sector. He launched www.NewCannabisVentures.com in late 2015.
You can follow Alan on Facebook (www.facebook.com/420investor) or on Twitter (https://twitter.com/Invest420). Alan also moderates a large LinkedIn group focused on the cannabis industry, Cannabis Investors & Entrepreneurs (https://www.linkedin.com/groups/6523904)
A deliberate investor, I make a substantial time and thought investment to analyzing the market from a financial, political, and social perspective to make the most comprehensive decisions.
I specialize in the healthcare industry in my analysis. I invest heavily in micro-cap biotechnology, materials, and energy as well as large-cap financials and technology.
Yaron “Ron” Reuven is the President & Chief Investment Officer of Reuven Capital Investments, LP. His expertise is in business valuations, financial model & theory analysis, and financial industry compliance. Throughout his 15 year career, Ron has been a valuable asset to many business owners and executives by managing their investments as well as advising them on countless business matters. Ron began his American dream at the age of 10 when his family emigrated from Israel to the United States. He became involved in business early on and has been exposed to a variety of industries and business models. This eclectic experience has cemented his distinctive investment and business philosophy. Establishing a FINRA MEMBER BROKER/DEALER when he was just 26 years old made Mr. Reuven one of the youngest individuals to ever independently open a FINRA member firm. Ron’s contrarian point of view and broad range of management, financial, and investment experience offers a unique value to the firm’s clients.
Yaron “Ron” Reuven began his career in the financial services industry at a New York City branch of First Union in 1999. There he began developing his own due diligence process and investment philosophy. By mid 2001, he was recruited by Raymond James Financial (NYSE:RJF), one of the largest financial services firms in the United States. At Raymond James, he began to implement his own concentrated investment philosophy and built strong relationships with his clients. Throughout one of the most difficult environments in market history Ron successfully became the third largest producing broker in the United States for Raymond James in August 2003.
Subsequently in an effort to expand the services and products he was able to offer his clients, Ron started a Wall Street office with another national independent broker/dealer based in Florida. He quickly became the firm’s largest producing broker and branch. In order to truly accomplish his long term goals, he realized that he and his team needed to be completely independent. In November 2006 REUVEN ENTERPRISES SECURITIES DIVISION (RESD) A FINRA/SIPC MEMBER FIRM AND MSRB LICENSED DEALER was founded. This was a massive undertaking which allowed Ron to truly implement his long term investment philosophy, and ultimately launch his hedge fund. In 2009 REUVEN CAPITAL INVESTMENTS, LP FUND (RCI) was launched. RCI is a long/short equity fund with a selectively concentrated portfolio. Ron’s ultimate goal for RCI is to have shareholder representation on the board of some of the companies the fund invests in.
Mr. Reuven is a NFL PLAYERS ASSOCIATION REGISTERED PLAYER FINANCIAL ADVISOR, and is involved with multiple charitable organizations, philanthropic work and public speaking. His unique philosophy, track record, and incisive financial commentary have been featured by Bloomberg, CNBC, NDTV, SNN WIRE, MANN, CNN, and GotGame.
MR. YARON “RON” REUVEN HOLDS THE FOLLOWING LICENSES:
Registered Options Principal (Series 4)
General Securities Representative (Series 7),
General Securities Principal (Series 24),
Municipal Securities Principal (Series 53),
Uniform Securities Agent State Law (Series 63),
Investment Banking Representative (Series 79)
Licensed Operations Professional (Series 99)
Licensed Life Insurance Agent and Registered Financial Planner RFP®
and CEO of Member FINRA Broker Dealer.
I've been contributing to SA since 2011, with a break to join the PRO editorial team from 2013-2015. I got my Series 7 and 63 back in 2000, and watched the dot-com bubble peak and then burst in real time at a small, tech-focused retail brokerage in NYC.
I began my professional career as a capital markets lawyer at the New York firm Cadwalader, Wickersham & Taft. In 2010, I returned to Notre Dame (’05 undergrad) for my MBA and graduated ('12) with an Investments concentration. I currently work as an equity analyst for an asset manager.
Please feel free to connect with me here or elsewhere--my linkedin profile is below:
I hold a PhD in the field of epidemiology a masters degree in public health. My undergraduate training is in policy, economics and the sciences. I have utilized my training in employment with government, academia, private industry and to further analyze the fundamentals and technicals of all manner of companies in different sectors. Specifically, I like to trade growth companies, REITS, biotechnology/ pharmaceuticals, precious metals, blue chips and small-cap companies.
Each market day I get up at 530 am and begin working/analyzing data before my day job. I focus much on current events, earnings, and developments. I also work after market hours to cover after hours developments or interesting action during the day. I aim to conduct 2 analysis per business day, which helps me stay focused on my own finances.
I have been investing for about 10 years. I also enjoy trading short expiration options, and investing in stocks with 3-20 year horizons. I enjoy writing with Seeking Alpha to share my opinion and analyses. I am a large believer in the crowd source model championed by Seeking Alpha and believe every ounce of analysis and opinion should be considered when you invest your personal finances.
Matthew Bradbard serves as a Director at RCM Alternatives & Attain Portfolio Advisors. Matthew began his career in the commodities business as an advisor to clients on asset allocation and buy/sell decisions. Matthew has devised, implemented and executed trading strategies for several firms since entering the commodity business in 2001. Matthew has also managed his own global macro CTA that traded numerous futures and options strategies and operated his own Introducing Broker for 5 years. A prolific commentator, Matthew has published subject-specific articles, market commentaries, and Managed Futures educational pieces for the last decade. Matthew is frequently interviewed for his opinion on commodities and current events as they relate to commodities and their role in an investor’s portfolios.
Efficient Alpha provides written content & investment research solutions for small and medium-sized advisor firms. Our core products include: financial newsletters, blogging, presentation preparation, investment research and ghost writing. Our normal clientele are small to medium-sized firms with research, analysis, or marketing needs but whom may have insufficient staff or topic expertise.
Joseph Hogue, founder and analyst, has more than ten years in the investment industry and holds the Chartered Financial Analyst designation. His experience covers a wide range of investment related areas but he specializes in web & social media content for financial advisors and other professionals. His work has been published by the International Economic Development Council, Alternative Latin Investor, Emerging Money, Morningstar, and the financial website Seeking Alpha. Mr. Hogue is also the administrator for the FinQuiz Blog, an online source for CFA exam preparation advice and preparation.
Working from Medellin, Colombia, he has worked for clients ranging from individual investors to large multinational firms. Prior to his work as a financial writer, Mr. Hogue worked as an economist for the State of Iowa, as a consultant on trade issues and analyzed real estate development deals in Colombia.
A veteran of the United States Marine Corps, Mr. Hogue is a graduate of Iowa State University with a B.S. in Finance, a B.A. in Communications, and a Master’s in Business Administration. He is the former Communications Chair on the board of directors for the CFA Society of Iowa.
Areas of Interest:
· Financial Blogging and Social Media Content
· Equity Research and Analysis
· Strategic Asset Allocation & Portfolio Planning
I'm from Milwaukee, WI and currently work for an energy focused asset manager. I've been investing since my Junior year of high school. I majored in Economics with minors in Math and German at DePauw University. I work in asset management with a focus on energy, financial services, and income derived from equities and call premiums.
My name is Difu Wu. I am an individual investor. I currently live in the US. My investment interests include gold, bonds, dividend stocks, value investing, index funds, small cap stocks, emerging markets, and international stocks. My favorite investment books are Security Analysis, by Graham and Dodd; Intelligent Investor, by Graham; Little Book of Common Sense Investing, by Bogle; Single Best Investment, by Miller; Secret Code of the Superior Investor, by Glassman; One Up on Wall Street, by Lynch. I welcome your comments and suggestions. Please do not hesitate to contact me. Thanks!
MHAF (Special Situations in Healthcare and Technology)
Fund concentrated in Special Situation growth stocks. We are proponents of only investing in ideas which we can evaluate ourselves (most sell-side research ideas are entirely biased due to investment banking relationships and are therefore almost always flawed).
Our ideas are our own.
Please do your own research as we do not make investment recommendations.
Our small-cap hedge fund strategy beat the market by 44 percentage points since its inception 18 months ago. Visit our website to learn how you can do the same. Insider Monkey is a finance website that provides free hedge fund and insider trading data. We believe ordinary investors can beat the market by imitating insiders and best hedge fund managers. They have access to better information and experts than ordinary investors do. Take advantage of the SEC filings where hedge funds and insiders disclose their stock transactions.
Here is our team:
Ms. Krishnamsetty is the Editor of Insider Monkey. Prior to creating Insider Monkey with Dr. Dogan, Ms. Krishnamsetty was Associate Producer at Bloomberg Television. Prior to that, Ms. Krishnamsetty was on the afternoon news team at CNBC. Additionally, Ms. Krishnamsetty reported for NPR and worked as a risk management consultant at Marsh & McLennan. Ms. Krishnamsetty has a M.S. in Journalism from Columbia University’s Graduate School of Journalism.
Insider Monkey’s hybrid evaluation system ...More was created in 2003 by Dr. Ian Dogan. Dr. Dogan has a Ph.D. in financial economics with a specialization in insider trading. Dr. Dogan has provided consulting services to institutional investors and hedge funds, and managed a $200+ million fund using a strategy he developed utilizing insider transactions. Dr. Dogan recently authored the insider trading chapter of soon to be published “The Handbook of Investment Anomalies” by Zacks Investment Research. Insider Monkey will serve the outcome of the methodologies developed by Dr. Dogan to ordinary investors who don’t have access to academic quality research and tools to shape their investments.
For your inquiries please contact us at email@example.com
Natty Greene is an avid investor who is always on the hunt for undiscovered small cap gems benefitting from secular growth trends with an eye toward those stocks with increased insider or institutional ownership and potential acquisition targets.
M.E. Garza is one of the founders of the biotech and healthcare sector news portal BioMedReports.com. He believes in getting the news from credible sources on the street and often reaches out to CEOs and newsmakers directly for interviews and discussions about their companies. Since he began publishing in 2008, Garza has built a reputation as a writer and reporter who can move markets. His track record for accurately reporting rumors and alerting readers about developments in the biotech/healthcare sector is unmatched during that time.